Pharmacoepigenomic impact of antihypertensive drugs on miRome and proteome and its potential impact on health and side effects

SUPPLEMENTARY FIGURES:

Figure S1: Methodology flow chart

Figure S2: MTT assay showing cell viability for different drug concentrations and time points

SUPPLEMENTARY TABLES:

Table S1: Significantly regulated miRNAs (P-values < 0.05) with the respective fold change

Table S2: The validated target genes (3' UTR binding, binding score ≥ 0.95) derived from miRwalk database

Table S3: Validated miRNA target genes associated with Hypertension

Table S4: Validated miRNA target genes and the side effects associated in terms of HPO database

Table S5: Significantly differentially regulated proteins